Active Ingredient History

  • Now
Anagliptin is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins".   Wikipedia

  • SMILES: Cl.Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N
  • Mol. Mass: 419.92
  • ALogP: 0.65
  • ChEMBL Molecule:
More Chemistry
anagliptin | anagliptin hcl | anagliptin hydrochloride | beskoa | n-(2-((2-((2s)-2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methyl pyrazolo(1,5-a)pyrimidine-6-carboxamide hydrochloride | suiny


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue